Document is current
Any future updates will be listed below
-
Authors
Ueno, Morio
Imai, Kojiro
Tomioka, Yasufumi
Horiguchi, Go
Kameda, Takanori
Teramukai, Satoshi
Tsujikawa, Akitaka
Inatomi, Tsutomu
Sotozono, Chie
Kinoshita, Shigeru
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP16bm0504002, JP19bk0104084)
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 17 July 2024
First Online: 2 October 2024
Declarations
:
: M. Ueno, Patent License Fee (Aurion Biotechnologies, CorneaGen), Honorarium for consulting (Aurion Biotechnologies), Honorarium for lecture (Kowa), Stock (Aurion Biotechnologies); K. Imai, Honorarium for consulting (Aurion Biotechnologies); Y. Tomioka, None; G. Horiguchi, None; T. Kameda, None; S. Teramukai, Payment or honoraria for Statistical Advisor (Daiichi-Sankyo, AtWorking, Sanofi, Chugai); A. Tsujikawa, None; T. Inatomi, None; C. Sotozono, Grant to the author’s institution (Santen, Sun Contact Lens, CorneaGen), Honorarium for consulting (Aurion Biotechnologies), Payment or honoraria for lectures (Otsuka, Senju, Santen, Kowa, Nitto medic); S. Kinoshita, Research grant (Santen, Otsuka, Senju), Patent License Fee (Aurion Biotechnologies, CorneaGen), Honorarium for consulting (Santen, Otsuka, Alcon, Novartis, Tarsus, Aurion Biotechnologies), Honorarium for lecture (Santen, Otsuka, Senju, Kowa, Alcon, Johnson & Johnson), Patents planned and issued (Aurion Biotechnologies), Stock (Aurion Biotechnologies).
